These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 8597508)
41. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347 [TBL] [Abstract][Full Text] [Related]
42. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
43. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141 [TBL] [Abstract][Full Text] [Related]
45. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma. Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836 [TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in the operative and palliative treatment of pancreatic cancer. Talar-Wojnarowska R; Gasiorowska A; Strzelczyk J; Janiak A; Malecka-Panas E Neoplasma; 2003; 50(5):383-7. PubMed ID: 14628094 [TBL] [Abstract][Full Text] [Related]
48. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990 [TBL] [Abstract][Full Text] [Related]
49. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital. Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197 [TBL] [Abstract][Full Text] [Related]
50. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma. Imamura M; Hosotani R; Kogire M Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446 [TBL] [Abstract][Full Text] [Related]
51. Laparoscopic distal pancreatectomy employing radical en bloc procedure for adenocarcinoma: Technical details and outcomes. Kawaguchi Y; Fuks D; Nomi T; Levard H; Gayet B Surgery; 2015 Jun; 157(6):1106-12. PubMed ID: 25704430 [TBL] [Abstract][Full Text] [Related]
52. A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer. Kasahara N; Noda H; Kakizawa N; Kato T; Watanabe F; Ichida K; Endo Y; Aizawa H; Rikiyama T Pancreatology; 2019 Jul; 19(5):686-694. PubMed ID: 31253497 [TBL] [Abstract][Full Text] [Related]
53. [Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports]. Chatelain D; Fléjou JF Ann Pathol; 2002 Oct; 22(5):422-31. PubMed ID: 12483163 [TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267 [TBL] [Abstract][Full Text] [Related]
55. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Schwarz RE; Smith DD Ann Surg Oncol; 2006 Sep; 13(9):1189-200. PubMed ID: 16955385 [TBL] [Abstract][Full Text] [Related]
56. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report. Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441 [TBL] [Abstract][Full Text] [Related]
57. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations. Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054 [TBL] [Abstract][Full Text] [Related]
58. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190 [TBL] [Abstract][Full Text] [Related]
59. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
60. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis. Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]